Gardiner Healthcare Acquisitions, a blank check company targeting high-growth healthcare businesses, filed on Friday with the SEC to raise up to $75 million in an initial public offering.
The Shaker Heights, OH-based company plans to raise $75 million by offering 7.5 million units at $10. Each unit consists of one share of common stock and one warrant, exercisable at $11.50. At the proposed deal size, Gardiner Healthcare Acquisitions would command a market value of $94 million.
The company is led by CEO and Chairman Marc Pelletier, a co-founder of co-sponsor Gardiner Founder, and the founder and former CEO, CFO, and CSO of clinical-stage drug developer Aeromics. The company is also co-sponsored by Chardan.
Gardiner Healthcare Acquisitions plans to target high-growth healthcare businesses, particularly those in the North American or European life sciences and medical technology sectors, with a specific focus on small and large molecule therapeutics.
Gardiner Healthcare Acquisitions was founded in 2021 and plans to list on the Nasdaq under the symbol GDNRU. The company filed confidentially on June 4, 2021. Chardan Capital Markets is the sole bookrunner on the deal.
